The role of nutrition in promoting growth in pre-term infants with bronchopulmonary dysplasia: a prospective non-randomised interventional cohort study by M.L. Giann&#236 et al.
Giannì et al. BMC Pediatrics 2014, 14:235
http://www.biomedcentral.com/1471-2431/14/235RESEARCH ARTICLE Open AccessThe role of nutrition in promoting growth in
pre-term infants with bronchopulmonary
dysplasia: a prospective non-randomised
interventional cohort study
Maria Lorella Giannì*, Paola Roggero, Maria Rosa Colnaghi, Pasqua Piemontese, Orsola Amato, Anna Orsi,
Laura Morlacchi and Fabio MoscaAbstract
Background: Pre-term infants who develop bronchopulmonary dysplasia (BPD) are at risk of postnatal growth failure.
It has been reported that energy expenditure is higher in infants with BPD than in those without BPD. The aim of the
study was to evaluate whether increasing the enteral energy intake of pre-term infants with BPD can improve post-natal
growth.
Methods: This prospective, non-randomised interventional cohort study was designed to assess growth in 57 preterm
infants with BPD (gestational age <32 weeks, birth weight <1500 g, and persistent oxygen dependency for up to 28 days
of life) fed individually tailored fortified breast milk and/or preterm formula, and a historical control group of 73 pre-term
infants with BPD fed breast milk fortified in accordance with the instructions of the manufacturer and/or pre-term formula.
Between-group differences in the continuous variables were analysed using Student’s t test or the Mann-Whitney test; the
discrete variables were compared using the chi-squared test. Linear regression analysis was used to investigate the
independent contribution of enteral energy intake to weight gain velocity.
Results: The duration of parenteral nutrition was similar in the historical and intervention groups (43.7 ± 30.9 vs 39.6 ±
17.4 days). After the withdrawal of parenteral nutrition, enteral energy intake was higher in the infants in the intervention
group with mild or moderate BPD (131 ± 6.3 vs 111 ± 4.6 kcal/kg/day; p < 0.0001) and in those with severe BPD (126 ± 5.3
vs 105 ± 5.1 kcal/kg/day; p < 0.0001), whereas enteral protein intake was similar (3.2 ± 0.27 vs 3.1 ± 0.23 g/kg/day).
Weight gain velocity was greater in the infants in the intervention group with mild or moderate BPD (14.7 ± 1.38 vs 11.5 ±
2 g/kg/day, p < 0.0001) and in those with severe BPD (11.9 ± 2.9 vs 8.9 ± 2.3 g/kg/day; p < 0.007). The percentage of infants
with post-natal growth retardation at 36 weeks of gestational age was higher in the historical group (75.3 vs 47.4; p = 0.02).
Conclusions: On the basis of the above findings, it seems that improved nutritional management promotes post-natal
ponderal growth in pre-term infants with BPD.
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Bronchopulmonary dysplasia (BPD) is one of the most
frequent morbidities affecting extremely pre-term infants.
Despite advances in medical and respiratory care, the inci-
dence of BPD has not decreased but remains about 42%
in infants born at a gestational age of 22-28 weeks [1].
Adequate nutrition plays a major role in modulating
lung development and maturation [2], and it has been
demonstrated that under-nutrition exacerbates the al-
veolar damage caused by hyperoxia in experimental
models and contributes to the development of emphy-
sema in humans [3,4].
It is difficult to ensure adequate nutritional support in
pre-term infants with BPD because of their increased re-
spiratory needs and the occurrence of chronic lung injury
[5]. Furthermore, a worsening in their respiratory status
frequently interrupts progress to full enteral nutrition be-
cause of more frequent feeding intolerance or clinicians’
concerns about aggressively increasing enteral feeds.
Consequently, the pre-term infants who develop BPD are
at high risk of post-natal growth failure [6].
Wemhoner et al. [7] have recently reported that a crit-
ical amount of enteral supply is essential for promoting
lung development and preventing BPD. They found that
pre-term infants who were subsequently diagnosed as
having BPD received less enteral protein and energy
during the first 14 days of life than infants who did not
develop BPD. It has also been reported that energy ex-
penditure is higher in infants with BPD than in those
without [8,9], and so the former may require a higher
energy intake in order to achieve sustained growth.
Although there are very few studies that have investi-
gated protein requirements in infants with BPD [5], it
can be assumed that their protein needs are similar to
those of infants without BPD. However, Huysman et al.
[10] found a lack of fat-free mass six weeks post-term in
pre-term infants with BPD, thus suggesting that their
protein intake may be inadequate. It is widely acknow-
ledged that it is important to give infants with BDP
calcium, phosphorus and vitamin D supplements in
order to prevent the occurrence of rickets and promote
fat-free mass deposition [5,11]. Supplementation with
other nutrients such as vitamin A, vitamin E and inositol
has also been investigated, but there there is no clear
evidence supporting their routine use in the nutritional
management of infants with BPD [5,11].
In order to test the hypothesis that preterm infants de-
veloping BPD would show greater weight gain velocity if
their enteral energy intake was higher than that of a his-
torical group of pre-term infants with BPD, the primary
aim of this study was to evaluate whether increasing the
enteral energy intake of pre-term infants with BPD
modulates post-natal growth. The secondary aim was to
investigate the independent contribution of enteralenergy intake to weight gain velocity in preterm infants
with BPD receiving enteral nutrition.
Methods
This prospective, non randomised interventional cohort
study was approved by the institutional Ethics Commit-
tee of the Fondazione Istituto di Ricovero e Cura a
Carattere Scientifico Cà Granda Ospedale Maggiore
Policlinico, Milan (Italy), and informed written consent
was obtained from the parents of the participants. The
study are reported following the STROBE guidelines for
cohort studies (for more details see Additional file 1).
Subjects
The intervention group consisted of infants admitted to
our Institution between January and December 2013, who
were compared with a historical group of infants admitted
between January 2011 and December 2012. The inclusion
criteria were a birth weight of <1500 g, a gestational age of
<32 weeks, and persistent oxygen dependency for up to
28 days of life; the exclusion criteria were death during
hospitalisation, early transferred to other units, and the
presence of congenital anomalies.
The recorded neonatal data were gestational age at birth;
birth weight; body length and head circumference; gender;
singleton pregnancy; Apgar scores at 1′ and 5′; the need of
tube feeding at discharge. The parameters recorded at
36 weeks of gestational age were the severity of broncho-
pulmonary dysplasia; the presence of post-natal growth re-
tardation; body weight and length, and head circumference.
The medications recorded included pre- and post-natal
steroids, artificial surfactants and diuretics. A record was
also made of the occurrence of patent ductus arteriosus,
surgical necrotising enterocolitis, intraventricular hemorrhage,
retinopathy of prematurity and sepsis, defined as the
presence of a positive blood culture. Respiratory support
was recorded as the number of days of assisted ventilation
and the number of days of supplemental oxygen therapy
at an FiO2 value >0.21.
Gestational age was based on the last menstrual period
and first-trimester ultrasonogram. The infants with a birth
weight in the <10th or ≥10th percentile for gestational age
on the basis of Fenton’s growth chart [12], were respectively
classified as having a weight that was small for gestational
age (SGA) or appropriate for gestational age (AGA). BDP
was defined as mild, moderate or severe on the basis of the
classification of Jobe and Bancalari [13]. Post-natal growth
retardation was defined as a weight at 36 weeks of gesta-
tional age that was in the <10th percentile for gestational
age on the basis of Fenton’s growth chart [12].
Nutritional regimens
The parenteral solutions were prepared by the hospital
pharmacy in accordance with medical prescriptions. They
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proteins on the first day of life, and up to 90–100 kcal/kg/
day and 4 g/kg/day of proteins within the first week. En-
teral feeding was started within 24 hours of post-natal life
using breast milk or pre-term formula in the absence of
breast milk (energy 83 kcal/100 mL; carbohydrates 8.4 g/
100 mL; proteins 2.9 g/100 mL; fat 4.1 g/100 mL). Wean-
ing from parenteral nutrition was scheduled in order to
obtain a weight gain velocity of ≥15 g/kg/day, with the
parenteral provision of macronutrients (especially pro-
teins) being gradually reduced and the intake of enteral
macronutrients increased on the basis of the infant’s
weight gain velocity [14].
The nutritional intervention focused on enteral nutri-
tion. When tolerated, an enteral intake of >100 mL/kg of
individually tailored fortified breast milk and/or pre-
term formula (in the case of no or insufficient breast
milk) was given with the addition of Duocal (Nutricia,
Germany) and MCT oil (Nestlé, Switzerland) in order to
reach a mean energy intake of between 120 and
150 kcal/kg/day. Carbohydrates and fat respectively
provided 50% and 35% of the total energy intake. In
addition, FM 85 (Nestlé) and Protifar (Nutricia) were
used to ensure a mean protein intake of ≥3.5 g/kg/day.
In the historical control group, breast milk was fortified
as indicated by the manufacturer (FM 85: 5 g/100 mL of
breast milk) when the infants tolerated an enteral intake
of >100 ml/kg/day. In the absence of breast milk or when
breast milk was insufficient, the infants were fed a pre-
term formula.
The infants in both groups received similar supplemen-
tations of calcium (140 mg/kg/day), phosphorus (90 mg/
kg/day) and vitamin D (800 IU/day).
Nutritional and growth data
Energy and protein enteral intakes were calculated daily
from the patients’ computerised medical charts.
Growth measurements
Growth was assessed by two medical investigators. Daily
body weight and weekly body length and head circumfe-
rence were measured using standard procedures [15].
Body mass was measured to the nearest 0.1 g using a pre-
cise electronic scale and body length to the nearest 1 mm
using a Harpenden neonatometer (Holtain Ltd., UK), and
head circumference to the nearest 1 mm using a non-
stretch measuring tape. Weight gain velocity was assessed
using the formula: [1000xln (Wn/W1)]/(Dn-D1), in which
W=weight in grams; D = day; 1 = beginning of the time
interval n = the end of the time interval [16].
Statistical analysis
The date are expressed as mean values and standard devi-
ations or the number and percentage of observations.Between-group differences in growth parameters, and en-
ergy and protein intakes were analysed using Student’s t
test or the Mann-Whitney test; the chi-squared test was
used to compare the discrete variables.
In order to investigate the independent contribution of
enteral energy intake to weight gain velocity while control-
ling for birth weight, gestational age, being a twin, gender,
the severity of BPD, the occurrence of co-morbidities
(patent ductus arteriosus, surgical necrotising enterocoli-
tis, intraventricular hemorrhage, retinopathy of prematur-
ity, and sepsis), diuretic therapy and enteral protein
intake, linear regression analysis was used to analyse the
pooled data of the infants in each group.
Statistical significance was set at a p value of 0.05 level.
All of the statistical analyses were made using SPSS soft-
ware, version 12 (SPSS Inc., Chicago, IL).
Results
The study involved a total of 130 infants, whose basic char-
acteristics are shown in Table 1. There was no statistically
significant between-group difference in the subjects’ basic
characteristics, the occurrence of comorbidities or the
medications received during hospitalisation (except for
diuretics, which were administered to a higher percentage
of infants in the intervention group). Similar percentages of
infants in the intervention and control group were fed
exclusively fortified breast milk (14% vs 17%), exclusively
pre-term formula (28% vs 26%), or both (57% vs 56).
Table 2 shows the anthropometric parameters at 36 weeks
of gestational age. Weight was significantly higher in the
intervention group, and the percentage of infants with
post-natal growth retardation was significantly higher in the
historical control group.
The mean duration of parenteral nutrition was similar
in the historical and intervention groups (43.7 ± 30.9 vs
39.6 ± 17.4 days; p = 0.8). After the withdrawal of paren-
teral nutrition, mean enteral energy intake was signifi-
cantly higher in the intervention group, whereas there
was no between-group difference in enteral protein in-
take. Weight gain velocity during enteral nutrition was
significantly higher in the intervention group (Table 3).
Regression analysis (R2 = 0.538, p < 0.0001) showed
that enteral energy intake was positively associated with
weight gain velocity during enteral nutrition (unstandar-
dised B coefficient 0.127), and inversely with the severity
of BDP (unstandardised B coefficient -2.92) and the
occurrence of necrotising enterocolitis (unstandardised
B coefficient -3.27).
Discussion
The findings of this study indicate that increasing the
enteral energy intake of pre-term infants with mild and
moderate BPD together with the provision of a protein
intake of 3 g/kg/day leads to a mean weight gain velocity
Table 1 Descriptive data
Intervention group (n = 57) Historical group (n = 73)
Birth weight, g 852 ± 253 854 ± 240
Gestational age, weeks 26 ± 2.2 26 ± 2.2
Males, n (%) 30 (52.6) 40 (54.8)
SGA, n (%) 15 (26.3) 19 (26.0)
Twins, n (%) 19 (33.3) 30 (41.1)
Apgar 1′ 5.1 (1.8) 5.0 (1.9)
Apgar 5′ 7.8 (0.9) 7.8 (1.05)
Infants receiving artificial surfactant, n (%) 50 (87.7) 63 (86.3)
Infants treated with prenatal steroids, n (%) 45 (78.9) 52 (71.2)
Infants treated with postnatal steroids, n (%) 19 (33) 14 (19.2)
Infants receiving diuretic therapy, n (%) 47 (82.5)* 33 (45.2)
Days of assisted ventilation 41.26 (51.13) 36.5(37.4)
Days of supplemental oxygen therapy 25.8 (26.1) 29.1 (30.7)
Mild and moderate BPD, n (%) 36 (63.2) 48 (65.7)
Severe BPD, n (%) 21 (36.8) 25 (34.2)
Patent ductus arteriosus, n (%) 36 (63.2) 43 (58.9)
Necrotizing enterocolitis, n (%) 2 (3.5) 3 (4.1)
Intraventricular hemorrhage, n (%) 10 (17.5) 19 (26.0)
Retinopathy of prematurity, n (%) 21 (36.8) 21 (28.8)
Sepsis, n (%) 7 (12.3) 15 (20.5)
Infants with tube feeding at discharge, n (%) 7 (9.6) 3 (5.3)
*p = <0.0001.
Mean values ± standard deviation, or absolute numbers (%).
SGA small for gestational age; BPD bronchopulmonary dysplasia.
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recommended by the American Academy of Pediatrics
[17]. In addition, the percentage of infants discharged
with post-natal retardation at 36 weeks of gestational
age was significantly lower in the intervention group. On
the other hand, the infants with severe BPD did not
achieve the same weight gain velocity during enteral nu-
trition, probably because of their extremely high respira-
tory needs [11]. Linear regression analysis showed that
enteral energy intake, the severity of BPD and the occur-
rence of necrotising enterocolitis were the main determi-
nants of weight gain velocity during enteral nutrition.
There was no significant between-group difference in
the percentage of infants receiving post-natal steroids orTable 2 Anthropometric parameters at 36 weeks of gestation
Interventio
Weight, g 1957 ± 402*
Length, cm 41.1 ± 3.7
Head circumference, cm 29.6 ± 1.7
Postnatal growth retardation, n (%) 27 (47.4)**
*p = 0.04; **p = 0.02.
Mean values ± standard deviation, or absolute numbers (%).in the number of days of assisted ventilation or supple-
mental oxygen therapy. It can be speculated that the
significantly higher percentage of infants receiving diur-
etic therapy in the intervention group was incidental as
the severity of BDP was similar in the two groups.
The greater weight gain velocity in the infants fed an in-
creased enteral energy intake may be partially explained
by the fact that infants with BPD require more energy to
support the increased work load involved in breathing and
maintaining metabolic rate [5,9]. We increased energy in-
take as it has been found that infants with BPD need more
calories than age-matched healthy controls [11]. However,
it must be noted that, although mean actual energy intake
ranged from 126 to 131 kcal/kg/day, BPD-related feedingal age





Table 3 Enteral nutritional data
Intervention group (n = 57) Historical group (n = 73)
Volume intake, mL/kg/day 142.5 ± 8.7 140.9 ± 8.5
Protein intake, g/kg/day 3.2 ± 0.27 3.1 ± 0.23
Mild and moderate BPD
Energy intake, kcal/kg/day 131 ± 6.3** 111 ± 4.6
Weight gain velocity, g/kg/d 14.7 ± 1.38** 11.5 ± 2
Severe BPD
Energy intake, kcal/kg/day 126 ± 5.3** 105 ± 5.1
Weight gain velocity, g/kg/d 11.9 ± 2.9* 8.9 ± 2.3
*p = 0.007; **p < 0.0001.
Mean values ± standard deviation.
BPD bronchopulmonary dysplasia.
Giannì et al. BMC Pediatrics 2014, 14:235 Page 5 of 6
http://www.biomedcentral.com/1471-2431/14/235difficulties prevented higher energy intakes that may have
promoted growth in the most severely affected infants. As
suggested by others [11], in order to meet further caloric
demands, we used fat rather than carbohydrates because
this allows energy supplementation using small volumes
and produces low amounts of carbon dioxide. Furthermore,
fat was increased rather than protein intake in order to
avoid protein oxidation and promote tissue accretion [18].
Although there are very few published data, it is assumed
that the proteins needs of infants with or without BPD are
similar [5]. However it has been suggested that infants with
BDP might have a greater need for proteins because their
relative lack of fat-free mass probably reflects inadequate
protein intake [10]. We could not reach our targeted protein
intake because of the occurrence of episodes of feeding in-
tolerance, and so actual protein intake was only 3.2 g/kg/day,
which is insufficient to meet the protein requirements of
especially the most severely affected infants.
It is widely acknowledged that calcium, phosphorus and
vitamin D supplementation is extremely important in order
to promote bone mineralisation in pre-term infants and pre-
vent the occurrence of osteopenia of prematurity [5,11], and
the infants in both groups received similar supplementations
of these nutrients. We decided not to give the infants in the
intervention group vitamin A or vitamin E supplements, or
supplements of other micronutrients such as inositol and
selenium because of the lack of any clear evidence that their
routine use is beneficial in infants with BDP [5,11].
Our results are consistent with previously published
data [19,20] indicating that improved nutritional strategies
can positively affect the growth of pre-term infants with
BPD, who frequently suffer from post-natal growth retard-
ation [6,21]. Madden et al. [19] found a significant in-
crease in mean weight z-scores and a decrease in the
proportion of infants with a mean weight z-score of <2 SD
at 20 months of corrected age in a cohort of extremely
low gestational age infants with BPD born in 2000-2003 in
comparison with a cohort of extremely low gestational age
infants with BPD born in 1996-1999. The authorsspeculated that the improvement in the growth outcomes
may have been due to changes in the infants’ nutritional
management, such as the use of more aggressive paren-
teral nutrition and more caloric post-discharge formulae.
Theile et al. [20] retrospectively studied 88 extremely low
birth weight infants with BPD, and found a reduction in
post-natal growth retardation at the time of hospital
discharge (as assessed on the basis of weight and head
circumference) in infants fed caloric-dense milk. However,
as we found that the improved weight gain in the infants
belonging to the intervention group was not associated
with an improvement in length gain, there may be some
concern about the quality of their growth because, al-
though accompanied by the provision of a sufficient pro-
tein intake, the increased caloric intake may have caused
relatively greater fat deposition [22]. On the other hand,
as it has been reported that infants with BDP show a lack
of both fat-free mass and fat mass deposition [10,23], it
can also be speculated that the high energy intake may
have allowed at least a partial recovery of fat mass and
that the recovery of fat-free mass may occur later. Further-
more, the increased caloric intake may have been used to
meet the high metabolic requirements of infants affected
by BDP, thus allowing the use of proteins for lean tissue
accretion and preventing protein oxidation.
The promotion of adequate ponderal growth is of major
importance as it has been associated with a favourable
neurodevelopment outcome throughout childhood [24,25].
It is also agreed that BPD has an unfavourable effect on the
cognitive outcome of children born very pre-term that
seems to persist into school age even in the absence of
severe brain lesions [26].
This clinically interesting study has three limitations.
First of all, as it was a prospective non- randomised inter-
ventional cohort study, it may have been affected by a
higher number of known and unknown confounders than
a randomised, controlled trial; secondly, the number of
enrolled infants was relatively small; and thirdly, the
infants’ body composition was not assessed.
Giannì et al. BMC Pediatrics 2014, 14:235 Page 6 of 6
http://www.biomedcentral.com/1471-2431/14/235Conclusions
The findings of this study suggest using nutritional supple-
ments to increase enteral energy intake in association with
an adequate protein intake promotes post-natal ponderal
growth in pre-term infants affected by BPD. However,
further studies are required in order to investigate the
quality of the growth.
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